Literature DB >> 3140122

Improved prognosis of renal microscopic polyarteritis in recent years.

G Fuiano1, J S Cameron, M Raftery, B H Hartley, D G Williams, C S Ogg.   

Abstract

To determine if the short- and long-term prognosis of renal micropolyarteritis (including Wegener's granulomatosis) had improved in our Unit in the last 5 years compared to our previous series from 1965 to 1980, we examined data from 26 recent patients, 1981-1986. Twenty were admitted during acute phase and six after a mean of 7.1 months of disease. The acute phase showed mild to severe impairment of renal function, and renal biopsies showed necrotising glomerulitis in all acute patients with extensive crescents in 67%. Acute patients (20) were treated with 'aggressive' immunosuppression including i.v. methylprednisolone (15), plasmapheresis (seven) and cyclophosphamide (ten). Chronic immunosuppressive treatment was continued in most patients. In the 20 acute-onset patients, life survival at 2 and 5 years was 77%; four of five deaths occurred during the acute phase in aged patients with severe renal failure. The notable improvement in life and kidney survival (only one patient underwent chronic dialysis) probably resulted from greater awareness of vasculitis in general practice with early referral of patients to specialised units, and to more aggressive treatment.

Entities:  

Mesh:

Year:  1988        PMID: 3140122     DOI: 10.1093/oxfordjournals.ndt.a091685

Source DB:  PubMed          Journal:  Nephrol Dial Transplant        ISSN: 0931-0509            Impact factor:   5.992


  10 in total

Review 1.  New horizons in renal vasculitis.

Authors:  J S Cameron
Journal:  Klin Wochenschr       Date:  1991-09-03

Review 2.  Renal involvement in primary vasculitides.

Authors:  R A Sinico; G D'Amico
Journal:  Clin Rev Allergy Immunol       Date:  1997       Impact factor: 8.667

3.  Microscopic polyarteritis: clinical features and treatment.

Authors:  H Rodgers; J A Guthrie; A M Brownjohn; J H Turney
Journal:  Postgrad Med J       Date:  1989-08       Impact factor: 2.401

Review 4.  Treatment of vasculitis.

Authors:  H G Taylor; A Samanta
Journal:  Br J Clin Pharmacol       Date:  1993-02       Impact factor: 4.335

5.  Vasculitis and rapidly progressive glomerulonephritis in the elderly.

Authors:  R M Higgins; D J Goldsmith; J Connolly; J E Scoble; B M Hendry; P Ackrill; M C Venning
Journal:  Postgrad Med J       Date:  1996-01       Impact factor: 2.401

6.  Effect of diagnostic delay on disease severity and outcome in glomerulonephritis caused by anti-neutrophil cytoplasmic antibodies.

Authors:  D P Lal; D J O'Donoghue; M Haeney
Journal:  J Clin Pathol       Date:  1996-11       Impact factor: 3.411

7.  Anti-neutrophil cytoplasmic auto-antibodies-associated vasculitis with pulmonary and renal involvement.

Authors:  G Pintos-Morell; A Roca-Comas; M A Naranjo; C Tural; E Abad; G Javier; J Prats
Journal:  Eur J Pediatr       Date:  1993-06       Impact factor: 3.183

8.  A nationwide survey of rapidly progressive glomerulonephritis in Japan: etiology, prognosis and treatment diversity.

Authors:  Akio Koyama; Kunihiro Yamagata; Hirofumi Makino; Yoshihiro Arimura; Takashi Wada; Kosaku Nitta; Hiroshi Nihei; Eri Muso; Yoshio Taguma; Hidekazu Shigematsu; Hideto Sakai; Yasuhiko Tomino; Seiichi Matsuo
Journal:  Clin Exp Nephrol       Date:  2009-06-17       Impact factor: 2.801

Review 9.  Vasculitides with predominantly renal involvement: influence of age on the mode of presentation.

Authors:  A Serra; R Romero
Journal:  Int Urol Nephrol       Date:  2002       Impact factor: 2.370

Review 10.  Renal disease and vasculitis.

Authors:  J S Cameron
Journal:  Pediatr Nephrol       Date:  1988-10       Impact factor: 3.714

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.